Le Lézard
Classified in: Health
Subjects: SLS, CFG

Sales of cancer medicines in Canada nearly tripled over the past decade


OTTAWA, ON, Oct. 27, 2020 /CNW/ - Today, the PMPRB, under the National Prescription Drug Utilization Information System (NPDUIS) initiative, released a chartbook on the market for oncology medicines in Canada.

The Oncology Medicines in Canada chartbook examines Canadian and international trends in the sales, pricing, market distribution, and treatment costs of oncology medicines from 2010 to 2019, highlighting the rapid growth in this increasingly significant market.

The chartbook finds that sales of oncology medicines in Canada have nearly tripled over the past decade, reaching $3.9 billion in 2019, or approximately 15% of all pharmaceutical spending. In addition, the market has shifted toward higher-cost drugs, as medicines with 28-day treatment costs exceeding $7,500 now account for more than half of overall Canadian oncology sales. In Canada's private drug plans, these high-cost therapies made up 43% of oncology drug costs in 2019, compared to 17% in 2010.

With an aging population expected to increase demand for cancer therapies, and a strong pipeline of oncology medicines under development, this fast-growing market is expected to continue to be an important consideration for Canadian patients, prescribers, and payers in years to come.

Quick Facts

Associated Links

Follow us on Twitter: @PMPRB_CEPMB

SOURCE Patented Medicine Prices Review Board


These press releases may also interest you

at 17:00
US Fertility ("USF") is providing notice of a recent incident that may affect the security of certain individuals' protected health information. USF provides IT platforms and services to several infertility clinics, including Georgia Reproductive...

at 16:45
908 Devices, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to...

at 16:35
CB2 Insights (CSE:CBII; OTCQB:...

at 16:15
Dr. Paul Lange, M.D., F.C.C.P., has been named medical director at Donor Alliance, the federally designated organ procurement organization serving Colorado and most of Wyoming. A board certified physician in pulmonary and critical care medicine,...

at 16:00
Amgen will present at the Evercore ISI Virtual HealthCONx Conference at 1:50 p.m. ET on Tuesday, Dec. 1, 2020. David M. Reese, M.D., executive vice president of Research and Development and Peter H. Griffith, executive vice president and chief...

at 16:00
E-Z-C Pak, the first physician formulated immune support pack composed of Echinacea, Zinc, and Vitamin C designed to reduce antibiotic overuse in cold and flu has surged in demand amid the COVID-19 outbreak. Company spokesperson Julianne Jahn...



News published on 27 october 2020 at 14:01 and distributed by: